Interpace Biosciences Inc
OTC:IDXG
Relative Value
The Relative Value of one
IDXG
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.71 USD,
Interpace Biosciences Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
IDXG Competitors Multiples
Interpace Biosciences Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Interpace Biosciences Inc
OTC:IDXG
|
7.6m USD | 0.2 | 1.6 | 1.1 | 1.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.1B USD | 0.2 | 207.1 | 13.7 | 13.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.3B USD | 0.3 | 11.9 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
61B EUR | 0.3 | 11.7 | 7.6 | 9.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.3B EUR | 1.2 | 24 | 10.5 | 16 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.6B EUR | 1.1 | 31.4 | 10 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 1.6 | 26.3 | 14.2 | 19.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.7B USD | 1.9 | 21.6 | 11.9 | 16 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.1B USD | 15.6 | -35.3 | -37.2 | -33.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.2B EUR | 0.6 | 15.3 | 6.2 | 13.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
9.2B USD | 0.7 | 12.2 | 7.1 | 9.7 |